LMOFX
Price
$47.49
Change
+$0.24 (+0.51%)
Updated
Sep 26 closing price
Net Assets
1.8B
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

LMOFX vs VIMSX

Header iconLMOFX vs VIMSX Comparison
Open Charts LMOFX vs VIMSXBanner chart's image
Patient Opportunity FI
Price$47.49
Change+$0.24 (+0.51%)
VolumeN/A
Net Assets1.8B
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
LMOFX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMOFX vs. VIMSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMOFX is a Hold and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. LMOFX (1.8B). VIMSX pays higher dividends than LMOFX: VIMSX (1.35) vs LMOFX (0.00). LMOFX was incepted earlier than VIMSX: LMOFX (22 years) vs VIMSX (27 years). LMOFX (1.83) is less costly to investors than VIMSX (0.17). LMOFX is a more actively managed with annual turnover of: 31.00 vs. VIMSX (16.00). LMOFX has a lower initial minimum investment than VIMSX: LMOFX (0) vs VIMSX (3000). LMOFX annual gain was more profitable for investors over the last year : 31.04 vs. VIMSX (11.57). VIMSX return over 5 years is better than : 70.75 vs. LMOFX (62.75).
LMOFXVIMSXLMOFX / VIMSX
Total Expense Ratio1.820.171,071%
Annual Report Gross Expense Ratio1.830.171,076%
Fund Existence22 years27 years-
Gain YTD20.47210.845189%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.8B199B1%
Annual Yield % from dividends0.001.35-
Returns for 1 year31.0411.57268%
Returns for 3 years92.2755.74166%
Returns for 5 years62.7570.7589%
Returns for 10 years156.15160.6697%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye